Frequent expression of MDR1 and MDR3 genes in acute myelocytic leukemia cells with t(8;21) (q22;q22)

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 473-479

  Mizutani, Minoru ^a   Yamaguchi, Motoko ^a   Miwa, Hiroshi ^a   Kawamura, Takahiro ^a   Okuno, Tatsuya ^a   Nishii, Kazuhiro ^a   Shiku, Hiroshi ^a   Kamada, Nanao ^b   Kita, Kenkichi ^a  

^a MIE UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

8; 21 translocation; acute myelocytic leukemia (AML); CD19; multidrug resistance gene 1 (MDR1); multidrug resistance gene 3 (MDR3)

Indexed keywords

CALCITRIOL; CD19 ANTIGEN; CD7 ANTIGEN; GLYCOPROTEIN P;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030900619     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.473     Document Type: Article

References (42)

1. Rowley JD: Identification of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet 16: 109-112, 1973.
2. Kamada N, Okada K, Oguma N, Tanaka R, Mikami M, Uchino H: C-G translocation in acute myelocytic leukemia with low neutrophil alkaline phosphatase activity. Cancer 37: 2380-2387, 1976.
3. Trujillo JM, Cork A, Ahearn MJ, Youness EL, McCredie KB: Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. Blood 53: 695-706, 1979.
4. Hagemeijer A, Garson OM, Kondo K: Fourth International Workshop on Chromosomes in Leukemia, 1982: Translocation (8;21) (q22;q22) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 11: 284-287, 1984.
5. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ: 8;21 translocation in acute granulocytic. leukaemia: cytological, cytochemical and clinical features. Br J Haematol 56: 199-213, 1984.
6. Koeffler HP: Syndromes of acute nonlymphocytic leukemia. Ann Intern Med 107: 748-758, 1987.
7. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (FAB Cooperative Group): Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103: 620-625, 1985.
8. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis: III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133: 157-165, 1984.
9. + cells. Blood 74: 1287-1294, 1989.
10. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21) (q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80: 470-477, 1992.
11. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D, Gottesman MM, Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538-4542, 1986.
12. Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389, 1986.
13. Hamada H, Tsuruo T: Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83: 7785-7789, 1986.
14. El Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, Newcomb EW: p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 82: 3452-3459, 1993.
15. Smit JJM, Schinkel AH, Oude Elferink RPJ, Grocn AK, Wagenaar E, van Deemter L, Mol CAAM, Ottcnhoff R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM, Borst P: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462, 1993.
16. Sato H, Preisler H, Day R, Raza A, Larson R, Browman G, Goldberg J, Vogler R, Grunwald H, Gottlieb A, Bennett J, Gottesman M, Pastan I: MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br J Haematol 75: 340-345, 1990.
17. Arceci RJ: Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 81: 2215-2222, 1993.
18. Maric JP, Zittoun R, Sikic BI: Multidrug resistance (mdrl) gene expression in adult acute leukemias: Correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 586-592, 1991.
19. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D: Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphocytic leukemia cells at diagnosis. Blood 79: 473-476, 1992.
20. Asou H, Tashiro S, Hanamoto K, Otsuji A, Kita K, Kamada N: Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosomal translocation. Blood 77: 2031-2036, 1991.
21. Collins SJ, Gallo RC, Gallagher RE: Continuos growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347-349, 1977.
22. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66: 85-94, 1991.
23. Herweijer H, Sonneveld P, Baas F, Nooter K: Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82: 1133-1140, 1990.
24. Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80: 2735-2739, 1992.
25. + acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 82: 3445-3451, 1993.
26. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T: Molecular structure of the cytoplasmic β-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82: 6133-6137, 1985.
27. 185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 162: 224-231, 1989.
28. Collins SJ: The HL-60 promyelocytic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 70: 1233-1244, 1987.
29. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y, Suda T: 1a, 25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophs Res Commun 102: 937-943, 1981.
30. Second MIC Cooperative Study Group: Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet Cytogenet 30: 1-15, 1988.
31. Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, Ludwig H, Lechner K: MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83: 708-712, 1991.
32. + acute myeloid leukemia cells. Blood 82: 3157-3162, 1993.
33. Zochbauer S, Gsur A, Brunner R, Kyrie PA, Lechner K, Pirker R: P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia 8: 974-977, 1994.
34. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Kamada N, Nasu K, Uchino H: Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 81: 2399-2405, 1993.
35. Nishii K, Kita K, Miwa H, Kawakami K, Nakase K, Masuya M, Morita N, Omay SB, Otsuji N, Fukumoto M, Shirakawa S: c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 6: 662-668, 1992.
36. - acute lymphoblastic leukemia. Leukemia 7: 1184-1190, 1993.
37. Zhou DC, Marie JP, Suberville AM, Zittoun R: Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 6: 879-885, 1992.
38. Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, Muller CP, Dopfer R, Klingebiel T, Diddens H, Probst H, Niethammer D: Mdr1/P-glycoprotein, topoisomerase, and glutathion-S-transferase π gene expression in primary, and relapsed state adult and childhood leukaemias. Br J Cancer 66: 507-517, 1992.
39. Marie JP, Legrand O, Russo D, Zhou D, Suberville AM, Zittoun R: Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis. Leuk Lymphoma 8: 261-265, 1992.
40. O'Brien S, Kantarjian HM, Keating M, Gagnon G, Cork A, Trujillo J, McCredie KB: Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosome 8 and 21. J Clin Oncol 7: 1081-1086, 1989.
41. Guerrasio A, Rosso C, Martinelli G, Lo Coco F, Pampinella M, Santro A, Lanza C, Allione B, Resegotti L, Saglio G: Polyclonal haematopoiesis associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continuous clinical remission. Br J Haematol 90: 364-368, 1995.
42. Tashiro S, Kyo T, Tanaka K, Oguma N, Hashimoto T, Dohy H, Kamada N: The prognostic value of cytogenctic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy. Cancer 70: 2809-2815, 1992.